share_log

Khiron Life Sciences Corp. (OTCMKTS:KHRNF) Sees Significant Increase in Short Interest

Khiron Life Sciences Corp. (OTCMKTS:KHRNF) Sees Significant Increase in Short Interest

Khron生命科學公司(OTCMKTS:KHRNF)在空頭股數上的業務大幅增長
Defense World ·  2022/07/31 13:01

Khiron Life Sciences Corp. (OTCMKTS:KHRNF – Get Rating) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 293,400 shares, a growth of 55.9% from the June 30th total of 188,200 shares. Based on an average daily trading volume, of 202,000 shares, the days-to-cover ratio is presently 1.5 days.

凱龍生命科學股份有限公司(OTCMKTS:KHRNF-GET Rating)是7月份新浪空頭股數實現大幅增長的領頭羊。截至7月15日,空頭股數共有29.34萬股,比6月30日的18.82萬股增長了55.9%。以日均成交量20.2萬股計算,目前天數與回補比率為1.5天。

Khiron Life Sciences Price Performance

科龍生命科學的價格表現

Shares of Khiron Life Sciences stock opened at $0.09 on Friday. Khiron Life Sciences has a one year low of $0.08 and a one year high of $0.28. The stock's fifty day moving average is $0.10 and its 200 day moving average is $0.14.

上週五,KhIron生命科學的股票開盤報0.09美元。凱龍生命科學的一年低點為0.08美元,一年高位為0.28美元。該股的50日移動均線切入位為0.10美元,200日移動均線切入位為0.14美元。

Get
到達
Khiron Life Sciences
科隆生命科學
alerts:
警報:

About Khiron Life Sciences

關於凱龍生命科學

(Get Rating)

(獲取評級)

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis.
Khron生命科學公司在拉丁美洲和歐洲作為一家綜合醫療和大麻公司運營。它通過健康服務、醫用大麻產品和健康產品細分市場進行運營。該公司專注於四氫大麻酚和大麻二醇(CBD)醫用大麻的種植、生產、分銷和出口。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on Khiron Life Sciences (KHRNF)
  • Procter's Earnings Start To Show Weakness In Q4
  • MarketBeat: Week in Review 7/25 – 7/29
  • The One Question You Have to Ask Before Investing in INTC Stock
  • Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
  • Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
  • 免費獲取StockNews.com關於Khron生命科學(KHRNF)的研究報告
  • 寶潔第四季度收益開始疲軟
  • MarketBeat:回顧一週7/25-7/29
  • 在投資INTC股票之前,你必須問一個問題
  • 家得寶:引領熊市的美麗而乏味的股票
  • CRISPR治療公司可能是隱藏在平坦視線中的登月計劃嗎?

Receive News & Ratings for Khiron Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Khiron Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

接受《凱龍生命科學日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Khron生命科學和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論